-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Downgrades Option Care Health to Neutral, Lowers Price Target to $32.05

Benzinga·10/09/2026 15:27:02
UBS analyst A.J. Rice downgrades Option Care Health (NASDAQ:OPCH) from Buy to Neutral and lowers the price target from $39 to $32.05.